DO NOT share the Omnilux CLEAR™ device with any other person. The Omnilux CLEAR™ device is for single person use only.
DO NOT use the Omnilux CLEAR™ device to treat any other conditions apart from those listed in the indications for use (mild to moderateacne vulgaris). The Omnilux CLEAR™ device has not been tested for any other conditions than those listed, and the risk is unknown.
DO NOT use the Omnilux CLEAR™ device if you are pregnant, planning on becoming pregnant or breastfeeding. Omnilux CLEAR™ has NOT been tested on pregnant or breast-feeding women and therefore the risk to the fetus, neonate or pregnant women is unknown. Unless cleared by your doctor.
DO NOT use the Omnilux CLEAR™ if you are a child under 14 years of age. The safety of the device for children younger than 14 years of age has NOT been tested and the risk is unknown.
DO NOT use the Omnilux CLEAR™ device if you suffer from light induced headaches.
DO NOT use the Omnilux CLEAR™ device if you suffer from any genetic conditions of the eyes. The Omnilux CLEAR™ device has NOT been tested on subjects who suffer with genetic conditions of the eyes and therefore the risks are unknown. If you are unsure about any related eye condition and using Omnilux CLEAR™ contact your ophthalmologist or eye doctor.
DO NOT use the Omnilux CLEAR™ device if you suffer from any photosensitive disorder (sensitization to light) of the eye. The Omnilux CLEAR™ device has NOT been tested on subjects who suffer with photosensitive disorders of the eye and therefore the risks are unknown. If you are unsure about any related eye condition and using Omnilux CLEAR™ contact your ophthalmologist or eye doctor.
DO NOT use the Omnilux CLEAR™ device if you suffer from lupus erythematosus, photosensitive eczema or albinism. If you use the Omnilux CLEAR™ device to treat lupus erythematosus, photosensitive eczema or albinism you may cause a severe skin reaction.
DO NOT use the Omnilux CLEAR™ device if you suffer from any photosensitive disorder (sensitization to light) of the skin. If you use the Omnilux CLEAR™ device and you suffer from a photosensitive disorder you may cause a severe reaction.
DO NOT use the Omnilux CLEAR™ device if you suffer from any photosensitive disorder (sensitization to light) of the skin. If you use the Omnilux CLEAR™ device and you suffer from a photosensitive disorder you may cause a severe reaction.
Photosensitivity is a common side effect of various medications. These can include certain antibiotics, chemotherapy drugs, and diuretics. If you are unsure about any medication you may be taking consult your healthcare provider.
Other substances not listed above can also cause photosensitivity.
Common examples of these substances are: St John's wort, coal tar, deodorants, antibacterial soaps, artificial sweeteners, naphthalene (mothballs), petroleum products,brightening agents found in laundry detergent, and cadmium sulphide (a chemical injected into the skin during tattooing).
There are some instances in which Omnilux CLEAR™ may prove unsuitable for an individual. Certain medical conditions or drugs may mean that an individual is unsuitable for the treatment.
Precautions due to drug induced photosensitivity.
If you are taking any of the drugs listed below, please read the comments section of the table carefully.
Drug Type
Anti-Arthritic
Specific Group or Common Name
Gold 50 or Ridaura
Comments
If YES, the treatment cannot be administered
Drug Type
Anti- Arthritic or Immunosuppressant
Specific Group or Common Name
Azathioprine (Imuran, Azasan)
Comments
If YES, the treatment can be administered as long as the medication has not been taken within the last 5 days.
Drug Type
Anti Arrythmic
Specific Group or Common Name
Amiodarone (Cordarone, Pacerone), Aratac
Comments
If YES, the treatment can be administered as long as the medication has not been taken within the last 5 days.
Drug Type
-
Specific Group or Common Name
Quinidine
Comments
If YES, and the client is currently on the medication it is at the discretion of the client as to whether they commence the treatment.
There is a 10/100 chance of a light reaction.
If the client has stopped taking the medication for ≥ 5days then the treatment can be administered.
Drug Type
Antibiotics
Specific Group or Common Name
Fluoroquinolones: Ciprofloxacin (Cipro), Levofloxacin (Levaquin), Lomefloxacin (Maxaquin), Norfloxacin (Noroxin), Ofloxacin (Floxin)
Tetracyclines: Demeclocycline (Declomycin), Doxycycline (Vibramycin), Minocycline (Minocin), Oxytetracycline(Terramycin)
Others: Azithromycin (Zithromax), Capreomycin (Capastat), Ceftazidime (Fortaz),cycloserine (Seromycin),Metronidazole (Flagyl), nalidixic acid (NegGram), pyrazinamide, sulfamethoxazole/ trimethoprim (Bactrim)
Comments
If YES, the treatment can be administered as long as the medication has not been taken within the last 5 days.
Drug Type
Anti-Cancer
Specific Group or Common Name
Bexarotene (Targretin), Capecitabine (Xeloda), Dacarbazine (DTIC), Epirubicin (Ellence), Fluorouracil (5-FU), Interferon alfa (Intron A, Alferon-N), Methotrexate (Mexate), Pentostatin (Nipent), Procarbazine (Matulane), Tretinoin, oral (Vesanoid), Vinblastine (Velban, Velbe)
Comments
If YES, and the client is currently on the medication it is at the discretion of the client as to whether they commence the treatment.
There is between a 1 /100 and 5/100 chance of a light reaction.
If the client has stopped taking the medication for ≥ 5days then the treatment can be administered
Drug Type
Anticonvulsants
Specific Group or Common Name
Carbamazepine (Tegretol), Felbamate (Felbatol), Gabapentin (Neurontin), Lamotrigine (Lamictal), Oxcarbazepine (Trileptal), Topiramate (Topamax), Valproic acid (Depakene)
Comments
If YES, and the client is currently on the medication it is at the discretion of the client as to whether they commence the treatment.
There is a 1/100 chance of a light reaction.
If the client has stopped taking the medication for ≥ 5days then the treatment can be administered.
Drug Type
Antifungals
Specific Group or Common Name
Flucytosine (Ancobon), Griseofulvin (Fulvicin, GrisPEG), Terconazole (Terazol) Voriconazole (VFEND)
Comments
If YES, the treatment can be administered as long as the medication has not been taken within the last 5 days.
Drug Type
Antihistamines
Specific Group or Common Name
Cetirizine (Zyrtec), Diphenhydramine (Benadryl), Loratadine (Claritin), Promethazine (Phenergan)
Comments
If YES, the treatment can be administered as long as the medication has not been taken within the last 5 days.
Drug Type
Antihypertensives
Specific Group or Common Name
Captopril (Capoten), Diltiazem (Cardizem, Tiazac), Enalapril (Vasotec), Nifedipine (Procardia), Sotalol (Betapace)
Comments
If YES, the treatment can be administered as long as the medication has not been taken within the last 5 days.
Drug Type
Antimalarial
Specific Group or Common Name
Chloroquine (Aralen), Hydroxychloroquine (Plaquenil), Pyrimethamine (Daraprim), Pyrimethamine/sulfadoxine (Fansidar), Quinine
Comments
If YES, the treatment can be administered as long as the medication has not been taken within the last 5 days
Drug Type
Antipsychotics
Specific Group or Common Name
Phenothiazines:Chlorpromazine (Thorazine), Fluphenazine (Prolixin), Perphenazine (Trilafon), Prochlorperazine (Compazine), Thioridazine (Mellaril), Trifluoperazine (Stelazine)
Comments
If YES, and the client is currently on the medication it is at the discretion of the client as to whether they commence the treatment.
There is between a 2/100 and 3/100 chance of a light reaction.
If the client has stopped taking the medication for ≥ 5days then the treatment can be administered.
Drug Type
Antiretroviral
Specific Group or Common Name
Ritonavir (Norvir), Saquinavir (Fortovase,Invirase), Zalcitabine (Hivid)
Comments
If YES, it is at the discretion of the client as to whether they commence the treatment. If YES, it is at the discretion of the client as to whether they commence the treatment.
There is approximately a 2/100 chance of a light reaction.
Drug Type
Antiviral
Specific Group or Common Name
Amantadine (Symmetrel), Acyclovir (Zovirax)
Comments
If YES, and the client is currently on the medication it is at the discretion of the client as to whether they commence the treatment.
There is approximately a 1/100 chance of a light reaction.
If the client has stopped taking the medication for ≥ 5days then the treatment can be administered.
Drug Type
Cardiovascular
Specific Group or Common Name
Thiazide diuretics:Bendroflumethiazide (Corzide), Chlorthalidone (Thalitone), Hydrochlorothiazide (Microzide), Hydroflumethiazide (Diucardin), Indapamide (Lozol), Methyclothiazide (Enduron), Metolazone (Zaroxolyn), Polythiazide (Renese)
Diuretics, Other:Furosemide (Lasix), Triamterene (Dyrenium)
Comments
If YES, the treatment can be administered as long as the medication has not been taken within the last 5 days.
Drug Type
Lipid regulators Other
Specific Group or Common Name
Fenofibrate (Tricor)
Comments
If YES, and the client is currently on the medication it is at the discretion of the client as to whether they commence the treatment.
There is a 10/100 chance of a light reaction.
If the client has stopped taking the medication for ≥ 5days then the treatment can be administered.
Drug Type
Non-steroidal antiinflammatory (NSAIDs) Analgesics
Specific Group or Common Name
Diclofenac (Voltaren, Cataflam), Naproxen (Anaprox)
Comments
If YES, and the client is currently on the medication it is at the discretion of the client as to whether they commence the treatment.
There is a <1/100 chance of a light reaction.
If the client has stopped taking the medication for ≥ 1 day, then the treatment can be administered.
Drug Type
Sedatives
Specific Group or Common Name
Alprazolam (Xanax), Chlordiazepoxide (Librium), Zaleplon (Sonata), Zolpidem (Ambien)
Comments
If YES, and the client is currently on the medication it is at the discretion of the client as to whether they commence the treatment.
There is a 1/100 chance of a light reaction.
If the client has stopped taking the medication for ≥ 5days then the treatment can be administered.
Drug Type
Statins
Specific Group or Common Name
Fluvastatin (Lescol), Lovastatin (Mevacor), Pravastatin (Pravachol), Simvastatin (Zocor)
Comments
If YES, and the client is currently on the medication it is at the discretion of the client as to whether they commence the treatment.
There is a <0.5/100 chance of a light reaction.
If the client has stopped taking the medication for ≥ 5days then the treatment can be administered.
Drug Type
Skin agents (acne)
Specific Group or Common Name
Isotretinoin (Accutane, Roaccutane) Tretinoin topical (Renova, Retin-A) Tazarotene (Tazorac)
Comments
If YES, and the client is currently on the medication it is at the discretion of the client as to whether they commence the treatment.
There is between a 5/100 and a 10/100 chance of a light reaction.
If the client has stopped taking the medication for ≥ 5days then the treatment can be administered.
Drug Type
Skin agents (hair)
Specific Group or Common Name
Coal tar, Minoxidil (Rogaine)
Comments
If YES, and the client is currently on the medication it is at the discretion of the client as to whether they commence the treatment.
There is <0.5/100 chance of a light reaction.
If the client has stopped taking the medication for ≥ 5days then the treatment can be administered.
